Abstract

Pancreatic cancers are widely recognized as a group of neoplasms with one of the poorest prognoses in oncology research. Despite the advances achieved in drug design and development, there is no effective cure for pancreatic cancers, and the current chemotherapeutic regimens increase the survival rate by only a few months. As an integral part of all modern drug discovery campaigns, computer-aided approaches can represent a promising alternative change to accelerate the early discovery of potent anti-pancreatic cancer agents. To date, however, most of the efforts made so far have focused on small series of structurally related chemicals, where the anti-pancreatic cancer activity has been measured against only one cancer cell line. In addition, no rational insight has been provided in the sense of unveiling the physicochemical aspects and the structural features that the molecules should possess to increase the anti-pancreatic cancer activity. This work reports the first multicellular target QSAR model base...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call